The aim of this study is verify the clinical tolerance of the inactivated, attenuated flu vaccine (Flumist®) in an egg-allergic population. More specifically, we will estimate the risk of severe allergic reactions in the 24 hours following vaccination with Flumist® in egg-allergic patients.